Third Harmonic Bio, Inc. (THRD) — Analyst outlook / Analyst consensus target is. Based on 5 analyst ratings, the consensus is bullish — 1 Buy, 4 Hold.
The consensus price target is $16.15 (low: $3.60, high: $23.00), representing an upside of 200.2% from the current price $5.38.
THRD Stock — 12-Month Price Forecast
$16.15
▲ +200.19% Upside
Average Price Target
Based on 5 Wall Street analysts offering 12-month price targets for Third Harmonic Bio, Inc., the average price target is $16.15, with a high forecast of $23.00, and a low forecast of $3.60.
The average price target represents a +200.19% change from the last price of $5.38.
Highest Price Target
$23.00
Average Price Target
$16.15
Lowest Price Target
$3.60
THRD Analyst Ratings
Hold
Based on 5 analysts giving stock ratings to Third Harmonic Bio, Inc. in the past 3 months
